Wealthstream Advisors, Inc. Adma Biologics, Inc. Transaction History
Wealthstream Advisors, Inc.
- $502 Million
- Q3 2024
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$371 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$361 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$259 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$251 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$171 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.91B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...